Literature DB >> 10801132

Low fidelity DNA synthesis by human DNA polymerase-eta.

T Matsuda1, K Bebenek, C Masutani, F Hanaoka, T A Kunkel.   

Abstract

A superfamily of DNA polymerases that bypass lesions in DNA has been described. Some family members are described as error-prone because mutations that inactivate the polymerase reduce damage-induced mutagenesis. In contrast, mutations in the skin cancer susceptibility gene XPV, which encodes DNA polymerase (pol)-eta, lead to increased ultraviolet-induced mutagenesis. This, and the fact that pol-eta primarily inserts adenines during efficient bypass of thymine-thymine dimers in vitro, has led to the description of pol-eta as error-free. However, here we show that human pol-eta copies undamaged DNA with much lower fidelity than any other template-dependent DNA polymerase studied. Pol-eta lacks an intrinsic proofreading exonuclease activity and, depending on the mismatch, makes one base substitution error for every 18 to 380 nucleotides synthesized. This very low fidelity indicates a relaxed requirement for correct base pairing geometry and indicates that the function of pol-eta may be tightly controlled to prevent potentially mutagenic DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10801132     DOI: 10.1038/35010014

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  130 in total

1.  Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells.

Authors:  P Kannouche; B C Broughton; M Volker; F Hanaoka; L H Mullenders; A R Lehmann
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

2.  The many faces of DNA polymerases: strategies for mutagenesis and for mutational avoidance.

Authors:  E C Friedberg; W J Feaver; V L Gerlach
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 3.  Hypermutation in bacteria and other cellular systems.

Authors:  B A Bridges
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

Review 4.  Transcription, beta-like DNA polymerases and hypermutation.

Authors:  C A Reynaud; S Frey; S Aoufouchi; A Faili; B Bertocci; A Dahan; E Flatter; F Delbos; S Storck; C Zober; J C Weill
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

5.  Accessibility of DNA polymerases to repair synthesis during nucleotide excision repair in yeast cell-free extracts.

Authors:  X Wu; D Guo; F Yuan; Z Wang
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

6.  The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 somatic hypermutation.

Authors:  H Zan; A Komori; Z Li; A Cerutti; A Schaffer; M F Flajnik; M Diaz; P Casali
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

7.  Two novel human and mouse DNA polymerases of the polX family.

Authors:  S Aoufouchi; E Flatter; A Dahan; A Faili; B Bertocci; S Storck; F Delbos; L Cocea; N Gupta; J C Weill; C A Reynaud
Journal:  Nucleic Acids Res       Date:  2000-09-15       Impact factor: 16.971

8.  Localization of DNA polymerases eta and iota to the replication machinery is tightly co-ordinated in human cells.

Authors:  Patricia Kannouche; Antonio R Fernández de Henestrosa; Barry Coull; Antonio E Vidal; Colin Gray; Daniel Zicha; Roger Woodgate; Alan R Lehmann
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

9.  Localization of DNA polymerases eta and iota to the replication machinery is tightly co-ordinated in human cells.

Authors:  Patricia Kannouche; Antonio R Fernández de Henestrosa; Barry Coull; Antonio E Vidal; Colin Gray; Daniel Zicha; Roger Woodgate; Alan R Lehmann
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

10.  Error-prone lesion bypass by human DNA polymerase eta.

Authors:  Y Zhang; F Yuan; X Wu; O Rechkoblit; J S Taylor; N E Geacintov; Z Wang
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.